Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 3
This trial looked at which treatment is better to help people with CLL who tested positive to the protein CD20 and who have other health problems.
People who took part were having treatment for CLL for the first time.
Recruitment start: 1 April 2010
Recruitment end: 5 July 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Christopher Fegan
Experimental Cancer Medicine Centre (ECMC)
Roche
Last reviewed: 16 March 2017
CRUK internal database number: 6323
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
